Page last updated: 2024-09-05

em 523 and candesartan cilexetil

em 523 has been researched along with candesartan cilexetil in 1 studies

Compound Research Comparison

Studies
(em 523)
Trials
(em 523)
Recent Studies (post-2010)
(em 523)
Studies
(candesartan cilexetil)
Trials
(candesartan cilexetil)
Recent Studies (post-2010) (candesartan cilexetil)
2610628151133

Protein Interaction Comparison

ProteinTaxonomyem 523 (IC50)candesartan cilexetil (IC50)
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.2
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)2.4547
DNA polymerase kappaHomo sapiens (human)7.4
DNA polymerase iotaHomo sapiens (human)6.2
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.7244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, H1

Reviews

1 review(s) available for em 523 and candesartan cilexetil

ArticleYear
[Receptor agonists and antagonists: the present and future].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1993, Volume: 38, Issue:11

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzodiazepinones; Biphenyl Compounds; Cholinergic Antagonists; Devazepide; Erythromycin; Imidazoles; Ligands; Losartan; Peptides; Receptors, Cholecystokinin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrazoles

1993